TABLE 3

Prediction of Cardiac Abnormalities: Uni- and Multivariate Analysis

		Univariate analysis			Multivariate analysis
Characteristic	df	P	OR	95% CI	P	OR	95% CI
Sex	1	0.760	0.8	0.19–3.35	0.142	^*
Age (y)	1	0.140	1.04	0.99–1.09	0.339	^*
Anne Arbor stage	1	0.882	0.94	0.41–2.12	0.694	^*
Mediastinal radiotherapy	1	0.718	1.30	0.31–5.39	0.711	^*
Cumulative doxorubicin dose (mg)	1	0.963	1.00	0.99–1.01	0.486	^*
Baseline LV SUV	1	0.030	0.18	0.03–0.85	<0.001	0.065	0.006–0.74
Follow-up time (d)	1	0.364	1.00	0.99–1.001	0.408	^*